Small molecule
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
158
NCT04571385
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 9, 2019
Completion: Jan 23, 2023
NCT06066099
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969
Phase: Phase 1
Start: Oct 4, 2023
Completion: Mar 14, 2025
Loading map...